Aim: The aim of this retrospective study was to evaluate the clinical usefulness of the thyrotropin-releasing hormone (TRH) test in children with suspected hypothalamic or pituitary dysfunction. Methods: We reviewed the case notes of all patients in whom a TRH test had been performed over a 6-year period. Group 1 (n = 85, 34 males, aged 0.9–18.8 years) was the reference group with no evidence of hypothalamic, pituitary or thyroid dysfunction. Group 2 (n = 42, 24 males, 0.1–18.0 years) were being investigated for possible pituitary or hypothalamic insufficiency. Results: In Group 1, thyrotropin (TSH) responses were higher in females than males (p < 0.01). In Group 2, TSH responses were normal for gender in 26 patients, subnormal in 5, and exaggerated/delayed in 11. Four patients with normal TSH responses and 4 with exaggerated/delayed responses had persistently low free thyroxine (FT4) or later developed low FT4 and were treated with thyroxine. All those with subnormal TSH responses had normal FT4 and were not treated. The TRH test did not reliably discriminate between hypothalamic and pituitary disorders. Conclusions: The TRH test did not give useful clinical information. Clinical decisions regarding thyroxine treatment were based on FT4, not the TRH test. The TRH test should be abandoned in paediatric practice.

Keywords:
Thyrotropin-releasing hormone stimulation test, Reference values, Hypothalamic-pituitary disorders, Children
1.
Fleischer N, Burgus R, Vale W, Dunn T, Guillemin R: Preliminary observations on the effect of synthetic thyrotropin-releasing factor on plasma thyrotropin levels in man. J Clin Endocrinol Metab 1970;31:109–112.
2.
Haigler ED, Pittman JA, Hershman JM, Baugh CM: Direct evaluation of pituitary thyrotropin reserve utilizing synthetic thyrotropin-releasing hormone. J Clin Endocrinol Metab 1971;33:573–581.
3.
Kaplan SL, Grumbach MM, Friesen HG, Costom BH: Thyrotropin-releasing factor effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab 1972;35:825–830.
4.
Faglia G, Beck-Peccoz P, Ambrosi B, Ferrari C, Neri V: Prolonged and exaggerated elevations in plasma thyrotropin after thyrotropin-releasing factor in patients with pituitary tumors. J Clin Endocrinol Metab 1971;33:999–1002.
5.
Costom BH, Grumbach MM, Kaplan SL: Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism. J Clin Invest 1971;50:2219–2225.
6.
Hall R, Ormston BJ, Besser GM, Cryer RJ: The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet 1972;i:759–763.
7.
Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P, Paracchi S: Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 1973;37:595–601.
8.
Gruneiro de Papendieck L, Iorcansky S, Rivarola MA, Heinrich JJ, Bergada C: Patterns of TSH response to TRH in children with hypopituitarism. J Pediatr 1982;100:387–392.
9.
Milner RD, Herber SM: Response to TRH in suspected hypopituitarism. Arch Dis Child 1983;58:195–197.
10.
Pavord SR, Girach A, Price DE, Absalom SR, Falconer-Smith J, Howlett TA: A retrospective audit of the combined pituitary function test, using the insulin stress test, TRH and GnRH in a district laboratory. Clin Endocrinol (Oxf) 1992;36:135–139.
11.
Burke CW: The pituitary megatest: outdated? Clin Endocrinol 1992;36:133–134.
12.
Hartoft-Nielsen M-L, Lange M, Rasmussen AK, Scherer S, Zimmermann-Belsing T, Feldt-Rasmussen U: Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm Res 2004;61:53–57.
13.
Westwood ME, Butler GE, McLellan AC, Barth JH: The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of 126 six cases. Clin Endocrinol (Oxf) 2000;52:727–733.
14.
Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT: Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 2003;88:5696–5703.
15.
Foley TP, Owings J, Hayford JT, Blizzard RM: Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency. J Clin Invest 1972;51:431–437.
16.
Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL: Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472–4479.
17.
Ormston BJ, Cryer RJ, Garry R, Besser GM, Hall R: Thyrotrophin-releasing hormone as a thyroid function test. Lancet 1971;ii:10–14.
18.
Faglia G, Bitensky L, Pinchera A, Ferrari C, Paracchi A, Beck-Peccoz P, Ambrosi B, Spada A: Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 1979;48:989–998.
19.
Kimura N, Arai K, Sahara Y, Suzuki H, Kimura N: Estradiol transcriptionally and posttranscriptionally upregulates thyrotropin-releasing hormone receptor messenger ribonucleic acid in the rat pituitary cells. Endocrinology 1994;134:432–440.
20.
Schomburg L, Bauer K: Regulation of the adenohypophyseal thyrotropin-releasing hormone-degrading ectoenzyme by estradiol. Endocrinology 1997;138:3587–3593.
21.
Paris F, Servant N, Terouanne B, Balaguer P, Nicolas JC, Sultan C: A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J Clin Endocrinol Metab 2002;87:791–797.
22.
McLaren EH, Hendricks S, Pimstone BL: Thyrotrophin responses to intravenous thyrotrophin-releasing hormone in patients with hypothalamic and pituitary disease. Clin Endocrinol (Oxf) 1974;3:113–122.
23.
Ormston BJ, Kilborn JR, Garry R, Amos J, Hall R: Further observations on the effect of synthetic thyrotropin-releasing hormone in man. Br Med J 1971;ii:199–202.
24.
Snyder PJ, Utiger RD: Response to thyrotropin-releasing hormone in normal man. J Clin Endocrinol Metab 1972;34:380–385.
25.
Sawin CT, Hershman JM: The TSH response to thyrotropin-releasing hormone in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones. J Clin Endocrinol Metab 1976;42:809–816.
26.
Patel YC, Burger HG: Serum thyrotropin in pituitary and/or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1973;37:190–196.
27.
Snyder PJ, Jacobs LS, Rabello MM, Sterling FH, Shore RN, Utiger RD, Daughaday WH: Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients. Ann Intern Med 1974;81:751–757.
28.
Jenkins JS, Gilbert CJ, Ang V: Hypothalamic-pituitary function in patients with craniopharyngiomas. J Clin Endocrinol Metab 1976;43:394–399.
29.
Cohen LE, Wondisford FE, Salvatoni A, Maghnie M, Brucker-Davis F, Weintraub BD, Radovick S: A ‘hot spot’ in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995;80:679–684.
30.
Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P: Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 2000;85:3631–3635.
31.
Darzy KH, Shalet SM: Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005;8:203–211.
32.
Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Muller J: A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 2003;88:136–140.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.